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Edited by Robert BaroukiAbstract The stomach was reported to synthesize and secrete
leptin mainly in the gastric lumen. Gastric leptin release is mark-
edly increased after food intake, by vagal cholinergic stimulation
and by cholecystokinin and secretin. Here we show that human
gastric MKN-74 cells produce leptin that increases upon chal-
lenge with cholecystokinin, insulin, glucocorticoids and all-trans
retinoic acid through activation of the leptin gene promoter. In
addition, we demonstrate that forskolin and BRL37344 which in-
creased cAMP levels, fail to aﬀect the activity of leptin gene pro-
moter in MKN74 expressing b3-adrenoceptor cells but, induce a
2-fold decrease in this activity in adipose 3T3-L1 cells. These
data described for the ﬁrst time, similarities and more interest-
ingly, diﬀerences in the regulation of the leptin gene promoter
in gastric cells as compared to adipocytes.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Leptin, a 16 kDa protein that is mainly produced by adi-
pose tissue [1], has been involved in the control of energy
balance via its hypothalamic receptor (Lep-R) [2,3]. Actu-
ally, leptin can be considered as a multifunctional hormone
that regulates not only body weight homeostasis, but also
neuroendocrine function, fertility, immune function, and
angiogenesis. This current status of leptin is consistent with
its production by various tissues and organs such as the pla-
centa [4], the skeletal muscles [5], the pituitary cells [6] and
the stomach [7,8]. In the stomach, leptin is mainly secreted
into the gastric lumen and some of the stomach-derived lep-
tin reaches the intestine in an active form [9–11]. Thus, it
was reported that gastric leptin entering the intestine can in-
crease the absorption of oligopeptides through the brush-
border transporter PepT1 [12], and enhance the uptake of
butyrate via the monocarboxylate carrier MCT-1 [13]. These
data argue for a physiological role of gastric leptin in the
control of intestinal functions.*Corresponding author. Fax: +33 1 42 28 87 65.
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doi:10.1016/j.febslet.2005.02.031The regulation of the leptin gene expression in adipose
cells has been extensively investigated and the molecular
mechanisms underlying such a regulation deﬁned [14,15]).
Adipose leptin mRNA levels are increased by glucocorti-
coids [16,17] [18] and insulin [19–21] and decreased by b-
adrenergic agonists [22–24]. Leptin gene expression is
induced by the adipocyte transcription factor, C/EBPa [25–
27] an eﬀect consistent with the identiﬁcation of C/EBP-
binding site on the proximal region of the leptin promoter
[28]. In contrast, ligands and activators of peroxisome prolif-
erator-activated receptors gamma (PPARc) that heterodi-
merize with retinoid X receptors, bind to PP responsive
element of the leptin promoter and reduce expression of lep-
tin [29]. Very few studies have reported that CCK stimulates
gastric leptin secretion in vivo in the rat [7] and expression
in isolated canine chief cells in vitro [30]. Moreover, leptin
secretion was enhanced after infusion of secretin, an acid
inhibitory hormone, [9] and after vagal stimulation [10] in
humans. However, to our knowledge, there is no report
on the regulation of the leptin gene promoter in the
stomach.
The present study was undertaken to examine the hor-
monal regulation of leptins gene promoter expression in
gastric MKN-74 in comparison to adipose 3T3-L1 cells.
The two nuclear receptors, retinoid acid receptors (RARs)
and the X receptors (RXRs) [31,32] are well known to serve
as active partners of peroxisome proliferator-activated recep-
tors (PPARs) which have been involved in leptin expression.
Thus, we determine whether an activation of these receptors
by all-trans retinoic acid (ATRA) could aﬀect the leptin pro-
moter in gastric cells. The data reported in this study, con-
stitute the ﬁrst demonstration of the similarities and more
interestingly the diﬀerences in the regulation of the leptin
gene promoter in gastric cells as compared to adipocytes.2. Materials and methods
2.1. Materials
Dulbeccos modiﬁed Eagles medium with Glutamax-I, fetal calf ser-
um, penicillin–streptomycin, EDTA-Trypsin, Lipofectamine and insu-
lin were obtained from Life Technologies (Cergy-Pontoise, France).
Cholecystokinin-octapeptide (CCK-8), all-trans retinoic acid (ATRA),
dexamethasone (DXM), forskolin (FSK), bacitracin and 3-isobutyl-1-
methylxanthine (IMBX) were purchased from Sigma Chemicals (Saint-
Quentin Fallavier, France). The b3-adrenoceptor agonist, BRL37344
was purchased from Interchim (Montluc¸on, France). Dual-luciferase
Reporter Assay System was purchased from Promega (Charbonnie`-
res, France).blished by Elsevier B.V. All rights reserved.
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The human gastric cancer cell line MKN-74 has been established
from a well-diﬀerentiated adenocarcinomas localized in the fundus
[33,34]. MKN-74 cells were grown in Dulbeccos modiﬁed Eagles med-
iumwithGlutamax-I plus 10% bovine calf serum, 100 IU/mL penicillin-
Streptomycin at 37 C in a humidiﬁed atmosphere (95% O2/5% CO2).
Preadipocytes 3T3-L1 cells were maintained in basal medium and in-
duced to diﬀerentiate into adipocytes as described previously [35] in a
medium consisting of basal medium supplemented with 500 nmol/L
insulin, 250 nmol/L DXM, and 250 mmol/L isobutylmethylxanthine.
Thereafter, fully diﬀerentiated 3T3-L1 adipocytes were maintained in
basal medium and used for the experiments below.
2.3. RT-PCR analysis
Total RNA was isolated from MKN-74 and 3T3-L1 cells using the
guanidium isothiocyanate-phenol-chloroform method as described by
Chomczynski and Sacchi [36]. First-strand cDNA synthesis from 3 lg
of total RNA was performed using a reverse transcriptase kit (Life
Technologies, Inc), according to the manufacturers instructions. The
oligonucleotides primers used were: for LEP: f5 0-CCCGGATTCCCT-
GACCTTATCCAAGATGG-3 0 and the r5 0-CCCTCGAGGAGTAG-
CCTGAAGCTTCCAG-3 0 (Accession No. HUMFPOH2); for human
CCK1 receptor: f5
0-CCCGAATTCTTGTACTCCTTGATATTCC-30
and r5 0- CCC CTC GAG TCA TGA TGG TAA AGG-3 0 (Accession
No. D85606); for human CCK2 receptor: f5
0-ATGCTCATCAT-
CGTGGTCCTG-3 0 and r5 0-GTGCCCTACCCCGTGTACACT-3 0
(Accession No. L07746); for human b3-adrenoceptor: f5 0-GCATGCT-
CCGTGGCCTCACGAGAA-3 0 and 5 0-CTGGCTCATGATGGGC-
GC-3 0 (Accession No. X70812); for human insulin receptor: f5 0-CAG-
CGAGAAACTGCATGGT-3 0 and r5 0-CATTGGACATGGTAGAG-
TCG-3 0.
Samples were denatured at 95 C for 3 min, then PCR was carried
out for 35 cycles of 1 min denaturation at 95 C, 1 min annealing at
60 C, and 2 min extension at 72 C. The ampliﬁcation was terminated
by a 10 min extension step at 72 C. Reverse transcriptase was omitted
from the controls to check that PCR ampliﬁcation did not result from
genomic DNA contamination. PCR products were separated by elec-
trophoresis in a 2% agarose gel. The gel was stained with ethidium bro-
mide and viewed under UV illumination. The expected sizes for PCR
products were 241 bp for human ob, 398 bp for human CCK-1 recep-
tor, 362 bp for human CCK-2 receptor; 525bp for b3-adrenoceptor and
770 bp for human insulin receptor.
2.4. Immunocytochemistry
MKN-74 cells were cultured on Labtek four compartments (Nunc,
France) as described above for 48 h. The cells rinsed with PBS, ﬁxed
10 min with 4% paraformaldehyde and treated 5 min with 3% H2O2
in distilled water to inhibit endogenous peroxidase activity. The cells
were incubated overnight at 4 C with rabbit polyclonal anti-human
leptin antibody diluted at 1:50 (BioVendor GmH, Heidelberg, Ger-
many). After washing, cells were further incubated with the aﬃnity-
puriﬁed biotinylated rabbit anti-goat IgG antibody (0.5%, Vector Lab-
oratories Inc., CA, USA), for 40 min at room temperature, washed and
then reacted with Vectastain ABC Reagent (1%) for 30 min at RT.
Immunohistochemical staining was performed using 3 0,3 0-diam-
inobenzidine hydrochloride as the peroxidase chromogen (Sigma, St
Louis, MI, USA). Controls. No immunostaining was observed after
prior incubation of leptin antiserum with the recombinant human lep-
tin at 10 lg/mL overnight at 4 C, and after omission of the primary
antibody from the incubating medium.2.5. Determination of leptin secretion
Gastric MKN-74 or adipose 3T3-L1 cells were cultured in 75 cm2
culture ﬂasks with 10 mL culture medium. At 80% conﬂuence culture
media were changed and cells were serum-deprived and incubated with
or without various eﬀectors for 12, 24, 48, and 96 h. The culture media
were collected and stored at 80 C. The cellular content was collected
and washed with PBS. The cells were homogenized in a buﬀer consist-
ing of HEPES 25 mM pH 7.8, 1% NP 40, PMSF 1 mM, Leupeptin,
Pepstatin and Aprotinin at 1 lg/lL. Samples were centrifuged at
12000 · g, 10 min at 4 C and supernatants were collected and stored
at 20 C until assayed. Leptin levels were determined using a human
or mouse leptin radioimmunoassay (RIA) kit (Linco Research, St.
Charles, MO, USA).2.6. Transient transfections
The leptin reporter gene plasmid (pGL3-dOb2) contains 2400 bp of
the human leptin gene 5 0-ﬂanking region ligand to the luciferase repor-
ter gene [26] was used. Using Lipofectamine (Life Technologies, Inc),
gastric MKN-74 and 3T3-L1 adipose cells (3 · 106) in 6-well culture
plates, were co-transfected with 500 ng of a leptin reporter gene plas-
mid (pGL3-dOb2) and 1 ng of a dual luciferase reporter gene was used
as a transfection control eﬃciency for 5 h in 2 mL/well of culture med-
ium. Afterwards the cells were incubated with or without diﬀerent
drugs for 24 h. A Luciferase assay (Promega, Dual-Luciferase Repor-
ter Assay System) was used to determine luciferase activity according
to the manufacturers instructions. This activity was then normalized
to Dual Luciferase activity as an internal control. Transfection eﬃ-
ciency was monitored by evaluating the activity of the control vector
pGL3-Basic. All transfections were performed in triplicate.
2.7. cAMP measurements
The levels of cAMP was measured as previously described in detail
[37]. Brieﬂy, MKN-74 cells were incubated for 1 h at 15 C in phos-
phate-buﬀered saline (pH 7) containing 1.4% (w/v) bovine serum albu-
min, 0.1% bacitracin, and 0.2 mM 3-isobutyl-1-methylxanthine
without or with 10 nM b3-adrenoceptor agonist BRL37344 or 10 lM
foskolin The reaction was stopped by addition of perchloric acid and
centrifuged 10 min at 4000 · g. cAMP present in the supernatants were
succinylated, and were measured by radioimmunoassay as described
[37].
2.8. Statistical analysis
The data in each experiment were expressed as means ± S.E.M.
They were analyzed by one-way analysis of variance (ANOVA) fol-
lowed if signiﬁcant, by Tukey–Kramer multiple comparison test. The
diﬀerences were considered signiﬁcant when P was <0.05.3. Results
3.1. Gastric MKN-74 cells express leptin and CCK-receptors
By RT-PCR analysis, a 235 bp PCR product was ampliﬁed
from MKN-74 total RNA extracts (Fig. 1A). cDNA sequenc-
ing (Genomexpress, Meylan, France) conﬁrmed that this PCR
product is 100% similar to the LEP gene.
Moreover, a 398 bp and a 362 bp PCR products (Fig. 1A)
were ampliﬁed by RT-PCR. cDNA sequencing (Genom-ex-
press, Meylan, France) conﬁrmed that these products were
100% similar to CCK-1 and CCK-2 receptor gene. Finally,
PCR products of 525 and 770 bp were ampliﬁed from
MKN-74 total RNA extracts which corresponded to human
b3-adrenoceptor and insulin receptor, respectively.
The leptin protein was evidenced by immunocytochemistry
studies showing leptin immunoreactivity in the cytoplasm
and on MKN-74 cell membrane (Fig. 1B). These cells secrete
leptin in culture as a function of time (Fig. 1C) with a very
low amount of leptin-immunoreactive protein at day 0 that in-
creased by 2-fold and 4-fold after 12 and 48 h of cell culture.
Collectively, these data indicate that MKN-74 cells represent
a suitable cell model for analyzing the regulation leptin genes
expression in response to various hormonal stimuli.
3.2. Regulation of leptin secretion from gastric MKN-74 and
adipose 3T3-L1 cells
The basal secretion of leptin over 24 h was 0.17 ± 0.07 ng/
mL which represented 2.3% of the total leptin content in gas-
tric MKN-74 cells. In diﬀerentiated adipose 3T3-L1 cells, this
basal secretion of leptin was 0.36 ± 0.1 ng/mL, also at very low
levels. The addition of CCK-8 to gastric MKN-74 (Fig. 2A)
and to diﬀerentiated adipose 3T3-L1 (Fig. 2B) cells induced
Fig. 2. Hormonal regulation of leptin secretion in gastric MKN-74
and in adipose 3T3-L1 cells. Gastric MKN-74 (A) and diﬀerentiated
adipose 3T3-L1 cells (B) were treated for 24 h with or without 10 nM
CCK8 (CCK), 10 nM BRL37344 (BRL), 20 nM insulin (INS), 100 nM
dexamethasone (DXM), 10 lM forskolin (FSK) and 10 lM all-trans
retinoic acid (ATRA). (C) The cells were treated for 48 h with or
without 10 nM BRL37344 (BRL),or forskolin (FSK). 24-h (A, B) or
48-h (C) immunoreactive leptin release in the culture medium was
determined by radioimmunoassay of leptin (RIA Kit fom Linco). Data
represent means ± S.E.M. for ﬁve independent experiments performed
in triplicate. \P < 0.05; \\P < 0.01; \\\P < 0.001 vs. control.
Fig. 1. MKN-74 cells expressed leptin and gut hormone receptors. (A)
RT-PCR analysis from total RNA isolated from MKN-74 cells. LEP
gene: -RT: omission of reverse transcriptase and PCR ampliﬁcation
with ob primers result in a PCR product of 241 bp. CCK-receptors:
-RT: omission of reverse transcriptase; CCK1-receptor (CCK-1R):
398 bp PCR product and CCK2-receptor (CCK-2R): a 362 bp PCR
product. b3-adrenoceptor. lanes 1 and 2: PCR ampliﬁcation with
human b3 primers result in a PCR product of 525 bp in two separate
samples. Insulin receptor: PCR ampliﬁcation with human insulin
receptor primers result in a PCR product of 770 bp. (B) Immunode-
tection of leptin protein in human MKN-74 cells. Immunostaining was
carried out with a speciﬁc antibody for leptin, followed by biotinylated
second antibody, streptavidine-peroxydase and diaminobenzidine.
Leptin immunoreactivity was visible in the intracytoplasmic compart-
ments and on the cell membrane (bar = 20 lm). Note that there is no
leptin immunostaining after preabsorption of anti-human leptin rabbit
polyclonal antibody with the recombinant human leptin at 10 lg/mL
overnight at 4 C. (C) Leptin secretion by gastric MKN-74 cells. Cells
were cultured as described in Section 2. The culture medium was
sampled at the indicated period of time for leptin determination by
radioimmunoassay (Linco Research, St. Charles, MO, USA). Each
point represents the mean ± 1S.E.M. of four independent experiments
performed in duplicate.
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insulin (20 nM), dexamethasone (DXM 100 nM) and ATRA
(1 lM) induced a similar 4-fold increase in leptin secretion
(Fig. 2A). However, in diﬀerentiated adipose 3T3-L1 cells,
there was an hierarchy of eﬃciency with DXM, inducing a
6-fold, ATRA a 4-fold and insulin a 2-fold enhancement of ba-
sal secretion of leptin (Fig. 2B).
Finally, addition of forskolin or BRL-37344, the b3-adreno-
ceptor agonist, did not show any signiﬁcant eﬀect on 24-h lep-
tin secretion by gastric MKN-74 (Fig. 2A) and by
diﬀerentiated adipose 3T3-L1 cells (Fig. 2B). However, after
48 h, forskolin or BRL-37344 did signiﬁcantly reduced leptin
secretion in diﬀerentiated 3T3-L1 cells but not, in gastric
MKN-74 cells (Fig. 2C). We next examined whether thesechanges in the leptins secretion in response to hormonal stim-
uli were associated with changes in the activity of the leptin
gene promoter.
3.3. Activity of the leptin promoter in gastric MKN-74 and
adipose 3T3-L1 cells
Transfection eﬃciency was monitored by evaluation of
pGL3-Basic activity of, the control vector. In comparison to
the promoterless parent vector, the LEP promoter pGL3-dOb2
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and to 1.5-fold in adipose 3T3-L1 cells.
In transfected gastric MKN-74 (Fig. 3A) or diﬀerentiated
adipose 3T3-L1 (Fig. 3B) cells, 1 nM CCK-8 induced a 1.6-
or 2.3-fold increase in luciferase activity. Dexamethasone
(100 nM) was similarly eﬃcient in increasing the luciferase
activity (2.7-fold increase) in both MKN-74 and 3T3-L1 cells.
In addition, upon challenge with 20 nM insulin, diﬀerentiated
3T3-L1 adipose as well as MKN-74 cells, exhibited a similar
1.7 fold increase in promoter activity. The addition of 1 lM
ATRA induced a 2.5-fold increase in luciferase activity in gas-
tric MKN-74 (Fig. 3A) and in diﬀerentiated adipose 3T3-L1
cells (Fig. 3B).
Neither the b3-adrenergic receptor agonist BRL37344 nor
the cAMP activator forskolin, had any eﬀect on luciferase
activity in gastric MKN-74 cells although they were able to in-
crease cAMP levels (Fig. 3A). Indeed, basal levels of cAMPFig. 3. Hormonal regulation of the human leptin promoter in gastric
MKN-74 and in adipose 3T3-L1 cells. Luciferase reporter plasmid
containing the leptin promoter or promoterless (basic) was transfected
into gastric MKN-74 and diﬀerentiated adipose 3T3-L1 cells as
described Section 2. The eﬃciency of the transfections studies
monitored by evaluation of the control vector pGL3-Basic activity in
comparison to the LEP promoter pGL3-dOb2 showed a 4-fold
luciferase expression in MKN-74 and a 1.5-fold in adipose 3T3-L1
cells. The cells were treated with or without 10 nM CCK8 (CCK),
10 nM BRL37344 (BRL), 20 nM insulin (INS), 100 nM dexametha-
sone (DXM), 10 lM forskolin (FSK) and 10 lM all-trans retinoic acid
(ATRA). Luciferase activity after 24 h was measured as described
Section 2 and normalized to dual Luciferase activity as an internal
control. The data calculated as ratio and expressed as means ± S.E.M.
for ﬁve independent experiments performed in triplicate. *P < 0.05;
**P < 0.01 vs. control.was 0.2 ± 0.7 pmol/mg protein in MKN-74 cells and these lev-
els increased up to 18.2 ± 2.9 and 10.2 ± 3.7 pmol cAMP/mg
protein (P < 0.001 vs CTRL) for 10 lM FSK and 10 nM
BRL37344. On the other hand, luciferase activity in diﬀerenti-
ated adipose 3T3-L1 cells were reduced by 2-fold by
BRL37344 and by forskolin (Fig. 3B).4. Discussion
The human and rat stomach produce leptin that is mainly
secreted in the gastric lumen [7,9]. The physiological role of
this pool of leptin has been somewhat clariﬁed by recent
studies demonstrating that it regulates a number of intestinal
functions (for review [38]) including the activation of the vis-
cero-sensitive aﬀerent neurones through leptin receptors on
the vagus nerve [39,40]. By contrast to the adipocyte leptin
gene, very few studies have concerned the regulation of
stomach-derived leptin expression. Here, we show that gas-
tric MKN-74 cells express not only leptin but also the intes-
tinal hormone CCK-1 and CCK-2 receptors, the b3-
adrenoceptor and the insulin receptor. Therefore, this cell
line represents a relevant and a suitable cellular model for
analyzing the expression of the leptin gene in gastric epithe-
lial cells in comparison to adipose cells.
First, we demonstrated that the intestinal food-inhibitory
peptide CCK, activates LEP promoter and increases leptin
secretion both in gastric MKN-74 and in diﬀerentiated adi-
pose 3T3-L1 cells. These data are consistent with earlier re-
ports showing that CCK increases leptin both in stomach
and in the WAT [41] and, that meal-induced leptin secretion
can be blocked by pre-treatment with CCK-receptors antag-
onists in rats [7,41]. These data are also in agreement with
the only in vitro study showing that CCK can enhance lep-
tins expression via the high-aﬃnity CCK-1 receptor in iso-
lated canine gastric chief cells which are pepsinogen- and
leptin-secreting cells [30]. Even though further studies are re-
quired to unravel the molecular mechanisms, CCK appears
to be a key molecule in the control of the LEP promoter
at least in the stomach.
Furthermore, we demonstrated that hormonal regulators of
adipocyte leptin expression are also involved in the regulation
of the stomach-derived leptin. Indeed, dexamethasone in-
creases leptin secretion from gastric MKN-74 cells, an eﬀect
which is associated with an increase in the activity of LEP pro-
moter. These data are consistent with in vivo as well as in vitro
results, demonstrating that glucocorticoids increase leptin
genes expression and leptin secretion in humans or rats
[42,43]. They ﬁt well with the identiﬁcation of a glucocorticoid
response element on the leptin gene [44]. Since gastric mucosa
expresses glucocorticoid receptors [45], it is likely that our data
reﬂect a transcriptional mechanism. Similarly to adipocyte
3T3-L1 cells, insulin enhances leptin secretion in gastric
MKN-74 cells through increased activity of the LEP promoter.
The regulation of leptin genes expression in adipose cells by
insulin has been extensively investigated. It is generally as-
sumed to have a stimulatory eﬀect both in vitro and in vivo
[21,46], through transcriptional mechanisms involving the
insulin response sequence on the leptin promoter [47]. Our
ﬁndings argue for a similar insulin regulatory pathway of lep-
tin expression in gastric MKN-74 cells and by extension in the
stomach.
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receptors in the regulation of leptin expression in adipose
tissue. The cellular response to retinoid acid is conferred
by two distinct classes of nuclear receptors termed RARs
and RXRs, with their transcriptional activity being recipro-
cally modulated by direct interactions of the two proteins
[31]. On the other hand, peroxisome proliferator-activated
receptors (PPARs) are well known to heterodimerize with
nuclear retinoid receptors [48–50] and to display a ligand-
dependent transcriptional activity through binding consensus
DNA sequences or response elements within the regulatory
regions of genes [44]. Previous studies demonstrated that
the activation of peroxisome proliferator-activated receptors
gamma (PPARc), an adipocyte-speciﬁc and a lipid-activated
transcription factor, potently reduced leptin genes expres-
sion [29,51] through binding to PPRE within the leptin gene
promoter [44]. In the present study, we clearly demonstrated
that ATRA which binds RARs [52] potently increases the
activity of the leptin gene promoter in gastric MKN-74 cells.
These data may indicate that ATRA is actually operating as
a functional inhibitor of RARs/PPARs binding to PPRE
[53] as it was previously reported for RXR agonists such
as LG100268 [54], 9-cis retinoic acid [52]. Our data are in
line with the expression of PPARc in these MKN cell lines
[55] and, of both RARs and RXRs in the gastric mucosa
[56]. Altogether, our data support a role of retinoic acid
in leptin expression conﬁrming in the stomach, the previous
reports on adipocyte leptin.
One of the major ﬁnding in this study is that, increasing intra-
cellular cAMP levels either by forskolin or by the b3-adrenocep-
tor agonist BRL37344, aﬀects neither LEP promoter activity
nor protein secretion in gastric MKN-74 cells. On the other
hand, the LEP promoter activity and leptin secretion is potently
reduced in adipocyte 3T3-L1 cells. This result in adipose cells
are consistent with earlier reports in which increased intracellu-
lar cAMP levels decreased expression of leptin mRNA and of
leptin secretion in the rat [16,57]. Such a cAMP down-regula-
tion of the leptin gene ﬁts with the presence of the cAMP
responsive element binding in the promoter of leptin gene
[28]. The above results are also consistent with the reported
b3-adrenoceptor agonists powerful inhibitory eﬀect on leptin
gene expression and on leptin production in the rodent adipose
tissue. The consensual inhibitory eﬀect of cAMP on adipocyte
leptin, contrasts however with its stimulatory eﬀect reported in
several non-adipose cells such as C6 glioma cells, GH3 pituitary
tumor cells [58,59]; MCF-7 breast cancer cells [60] and placen-
tal choronic tissue [61]. Taken together, these results strongly
suggest a cell-speciﬁc diﬀerence in the intracellular cAMP reg-
ulation of leptin gene expression. We have no clear explanation
for the lack of response of gastric MKN-74 cells in terms of
LEP promoter activity to a b3-adrenoceptor agonist. However,
this may probably suggest a negligible role of the sympathetic
system in the regulation of leptin gene expression in the stom-
ach. The molecular mechanisms underlying the current ﬁndings
remained to be determined.
In summary, we described for the ﬁrst time, similarities and
more interestingly, diﬀerences in the regulation of the leptin
gene promoter in gastric cells as compared to adipocytes. Fur-
ther studies are required to determine the physiological rele-
vance of such diﬀerences and to provide further insight into
the mechanisms governing the leptin promoter in gastric
epithelial cells.Acknowledgement: He´le`ne Goı¨ot was supported by ARC (Association
pour la Recherche sur le Cancer).References
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